A detailed history of Baird Financial Group, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Baird Financial Group, Inc. holds 2,112,242 shares of ABBV stock, worth $380 Million. This represents 0.83% of its overall portfolio holdings.

Number of Shares
2,112,242
Previous 2,130,611 0.86%
Holding current value
$380 Million
Previous $365 Million 14.14%
% of portfolio
0.83%
Previous 0.77%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$163.84 - $199.33 $3.01 Million - $3.66 Million
-18,369 Reduced 0.86%
2,112,242 $417 Million
Q2 2024

Aug 13, 2024

SELL
$154.79 - $180.76 $4.16 Million - $4.86 Million
-26,898 Reduced 1.25%
2,130,611 $365 Million
Q1 2024

May 14, 2024

BUY
$159.82 - $182.1 $9.88 Million - $11.3 Million
61,842 Added 2.95%
2,157,509 $393 Million
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $1.7 Million - $1.92 Million
12,389 Added 0.59%
2,095,667 $325 Million
Q3 2023

Nov 13, 2023

SELL
$133.59 - $154.65 $4.96 Million - $5.74 Million
-37,109 Reduced 1.75%
2,083,278 $311 Million
Q2 2023

Aug 11, 2023

SELL
$132.51 - $164.9 $35 Million - $43.5 Million
-264,013 Reduced 11.07%
2,120,387 $286 Million
Q1 2023

May 15, 2023

BUY
$144.61 - $166.54 $3.44 Million - $3.96 Million
23,768 Added 1.01%
2,384,400 $380 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $46.2 Million - $53 Million
-344,486 Reduced 10.96%
2,799,687 $376 Million
Q2 2022

Aug 08, 2022

SELL
$137.62 - $174.96 $14.1 Million - $18 Million
-102,798 Reduced 3.17%
3,144,173 $482 Million
Q1 2022

May 13, 2022

BUY
$131.98 - $163.75 $4.42 Million - $5.48 Million
33,492 Added 1.04%
3,246,971 $526 Million
Q4 2021

Feb 09, 2022

BUY
$107.43 - $135.93 $2.46 Million - $3.11 Million
22,876 Added 0.72%
3,213,479 $435 Million
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $2.3 Million - $2.61 Million
21,610 Added 0.68%
3,190,603 $344 Million
Q2 2021

Aug 11, 2021

BUY
$105.21 - $117.21 $1.25 Million - $1.4 Million
11,928 Added 0.38%
3,168,993 $357 Million
Q1 2021

May 13, 2021

BUY
$102.3 - $112.62 $3.4 Million - $3.75 Million
33,276 Added 1.07%
3,157,065 $342 Million
Q4 2020

Feb 11, 2021

BUY
$80.49 - $108.67 $6.54 Million - $8.84 Million
81,305 Added 2.67%
3,123,789 $335 Million
Q3 2020

Nov 12, 2020

SELL
$85.91 - $100.83 $4 Million - $4.7 Million
-46,566 Reduced 1.51%
3,042,484 $266 Million
Q2 2020

Oct 22, 2020

BUY
$73.37 - $98.18 $14.6 Million - $19.6 Million
199,197 Added 6.89%
3,089,050 $303 Million
Q2 2020

Aug 14, 2020

SELL
$73.37 - $98.18 $421,070 - $563,455
-5,739 Reduced 0.2%
2,889,853 $259 Million
Q1 2020

May 14, 2020

SELL
$64.5 - $97.79 $889,648 - $1.35 Million
-13,793 Reduced 0.47%
2,895,592 $221 Million
Q4 2019

Feb 14, 2020

BUY
$72.13 - $90.25 $9.08 Million - $11.4 Million
125,945 Added 4.52%
2,909,385 $258 Million
Q3 2019

Nov 14, 2019

BUY
$62.98 - $75.72 $7.53 Million - $9.05 Million
119,496 Added 4.49%
2,783,440 $211 Million
Q2 2019

Aug 14, 2019

BUY
$65.7 - $83.98 $54.7 Million - $69.9 Million
832,875 Added 45.49%
2,663,944 $194 Million
Q1 2019

May 14, 2019

BUY
$77.14 - $90.79 $1.92 Million - $2.26 Million
24,932 Added 1.38%
1,831,069 $148 Million
Q4 2018

Feb 14, 2019

BUY
$77.85 - $96.01 $30.6 Million - $37.7 Million
393,186 Added 27.83%
1,806,137 $167 Million
Q3 2018

Nov 13, 2018

SELL
$88.91 - $98.84 $24.1 Million - $26.8 Million
-271,470 Reduced 16.12%
1,412,951 $134 Million
Q2 2018

Aug 13, 2018

BUY
$89.78 - $106.23 $10.7 Million - $12.6 Million
118,903 Added 7.6%
1,684,421 $156 Million
Q1 2018

May 14, 2018

SELL
$92.01 - $123.21 $11.7 Million - $15.6 Million
-126,739 Reduced 7.49%
1,565,518 $148 Million
Q4 2017

Feb 09, 2018

SELL
$89.56 - $98.21 $4.79 Million - $5.25 Million
-53,454 Reduced 3.06%
1,692,257 $164 Million
Q3 2017

Nov 14, 2017

SELL
$69.85 - $89.22 $12.8 Million - $16.4 Million
-183,767 Reduced 9.52%
1,745,711 $155 Million
Q2 2017

Aug 14, 2017

BUY
N/A
1,929,478
1,929,478 $140 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Baird Financial Group, Inc. Portfolio

Follow Baird Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baird Financial Group, Inc. with notifications on news.